Certification Rate
92.5%
Moderate DOL cert
2026 data Public-data reference Official source
KBI Biopharma, Inc.
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 67
- DOL-certified
- 92.5%
- Median offered wage
- $108,612
Durham, NC NAICS: 541715
How many H-1B LCA filings list KBI Biopharma, Inc.?
U.S. Department of Labor's OFLC discloses 67 Labor Condition Application filings naming KBI Biopharma, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
How many H-1B petitions has USCIS approved for KBI Biopharma, Inc.?
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 125 H-1B petitions naming KBI Biopharma, Inc. through FY2024, and approved the large majority of them: 96.8% approved (121 approvals, 4 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
KBI Biopharma, Inc. is listed in 67 DOL LCA filings, more filings than 97% of employer filers in this extract. DOL certified 92.5% of those LCAs; the median listed offered wage is $108,612. This is not a USCIS approval, hiring, or sponsorship ranking.
- 67
- DOL LCA filings, FY2023–FY2026
- 92.5%
- DOL-certified
- $108,612
- median offered wage
- Top 3%
- of employer filers by volume
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Durham, NC.
KBI Biopharma, Inc. LCA outcome mix
67DOL LCA filings on record
Saved on this device only, no account, no email.
Open saved list
Follow this profile's data updates
Updates when the published DOL data vintage changes; this is a feed, not an alert service.
KBI Biopharma, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
67 3970th of 122824 higher than 118,854 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
LCA filing shape · KBI Biopharma, Inc.
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $45,000–$222,500 .
Title concentration
- Scientist I 7 · 10.4% · $92,303
- Scientist I/Data Reviewer 6 · 9% · $95,667
- Software Engineer II 4 · 6% · $120,000
- Research Associate II 3 · 4.5% · $62,807
- Engineer III 3 · 4.5% · $112,667
Worksite counties
- DURHAM, NC 48 · 85.7%
- WAKE, NC 4 · 7.1%
- BOULDER, CO 2 · 3.6%
- COLLIN, TX 1 · 1.8%
- MONTGOMERY, TX 1 · 1.8%
DOL LCA release change
What changed between the two LCA fiscal years
- KBI Biopharma, Inc.'s disclosed H-1B LCA filing count rose from 11 in FY2024 to 28 in FY2025 (+154.5%).
- KBI Biopharma, Inc.'s average disclosed H-1B offered wage rose from $102,220 in FY2024 to $117,352 in FY2025 (+14.8%).
Above-prevailing wage posture
On 67 LCAs with comparable offered vs prevailing wages, KBI Biopharma, Inc. averages about 11.7% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Qualified (Level II) (28.4% of LCA filings).
Durham, NC worksite concentration
Only 67 LCAs on file for KBI Biopharma, Inc., and 71.6% land in DURHAM, NC. Treat rates as descriptive of a small sample. DOL cert on file: 92.5%.
Avg. Salary
$108,612
Near portal avg
Total Workers
67
Moderate worker count
Wondering how long it takes USCIS to process an H-1B petition for this employer?
See current I-129 processing times →
Salary Analysis
Compensation range for H-1B positions at KBI Biopharma, Inc.
Minimum
$45,000
Maximum
$222,500
Average Salary
$108,612
Wage vs. DOL Minimum
+11.7%
At/above DOL floor
national avg +17.8%
Typical DOL Wage Level
Qualified (Level II)
28.4% of LCA filings
Full-Time Positions
100%
Primary Worksite County
DURHAM, NC
71.6% of LCA filings
Top Occupations
Most frequently listed job titles at KBI Biopharma, Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Scientist I | 7 | $92,303 |
| Scientist I/Data Reviewer | 6 | $95,667 |
| Software Engineer II | 4 | $120,000 |
| Research Associate II | 3 | $62,807 |
| Engineer III | 3 | $112,667 |
| Senior QA Specialist | 2 | $91,000 |
| Senior Computer Systems Validation Specialist | 2 | $125,947 |
| Process Development Data Reviewer/ Senior Research Associate | 2 | $84,800 |
| Manufacturing Sciences Engineer III, Downstream | 2 | $98,215 |
| MS&T Downstream Engineer I | 2 | $72,000 |
| Director, Process Development | 2 | $204,000 |
| Director of Facilities | 2 | $184,000 |
| Validation Engineer III | 1 | $109,741 |
| Validation Engineer II | 1 | $93,038 |
| Senior Validation Engineer | 1 | $138,000 |
Nationwide peers near KBI Biopharma, Inc.'s 67-LCA band
Cross-state DOL neighbors for KBI Biopharma, Inc. - LCA filing-count and offered-wage axes, outside NC.
Similar LCA filing volume
Nearest cross-state employer filers by LCA filing count (67 here; floor ≥10 LCA filings).
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($108,612 here).
Frequently Asked Questions
How many H-1B LCA filings list KBI Biopharma, Inc.?
KBI Biopharma, Inc. is listed in 67 DOL Labor Condition Application filings covering 67 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
How does KBI Biopharma, Inc.'s LCA filing volume compare to other employer filers?
Among 122,824 employer filers in the DOL disclosure extract, KBI Biopharma, Inc. ranks #3907 by total LCA filing count (67 filings). 118,854 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
What is the H-1B DOL certification rate for KBI Biopharma, Inc.?
KBI Biopharma, Inc. has a 92.5% DOL certification rate, with 62 out of 67 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
What offered wage is listed in LCAs for KBI Biopharma, Inc.?
The average offered wage listed in KBI Biopharma, Inc.'s LCAs is $108,612. Listed wages range from $45,000 to $222,500 and are not verified actual compensation.
What are the most common H-1B job titles at KBI Biopharma, Inc.?
The top job titles in KBI Biopharma, Inc.'s LCA filing records include Scientist I, Scientist I/Data Reviewer, Software Engineer II. The most common listed title is Scientist I with 7 LCA filings at an average listed offered wage of $92,303. This does not establish actual job openings, hiring, or approved petitions.
Where is KBI Biopharma, Inc. located?
KBI Biopharma, Inc. is headquartered in Durham, NC. Their H-1B workers are distributed across 4 states, with the most positions in NC, WA, CO.
Is KBI Biopharma, Inc. H-1B dependent?
No, KBI Biopharma, Inc. is not classified as H-1B dependent.
How have KBI Biopharma, Inc.'s listed LCA filings changed over time?
KBI Biopharma, Inc. is listed in 20 LCA filings in FY2023 and 8 in FY2026. The average listed offered wage increased from $88,635 to $136,750. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
Read with KBI Biopharma, Inc.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-SOLID · WAGE-PAR.
Aditi LLC · MICRO-BOOK
ABS(total_petitions) peer at 67 LCAs (Δ 0 heavier vs KBI Biopharma, Inc.); CERT-SOLID · WAGE-BELOW vs this page's MICRO-BOOK · CERT-SOLID · WAGE-PAR.
Akvarr, INC. · MICRO-BOOK
ABS(total_petitions) peer at 67 LCAs (Δ 0 heavier vs KBI Biopharma, Inc.); CERT-SOFT · WAGE-BELOW vs this page's MICRO-BOOK · CERT-SOLID · WAGE-PAR.
Altera Digital Health, Inc. · MICRO-BOOK
ABS(total_petitions) peer at 67 LCAs (Δ 0 heavier vs KBI Biopharma, Inc.); CERT-LOCK · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-SOLID · WAGE-PAR.
Ammadar, LLC · MICRO-BOOK
ABS(total_petitions) peer at 67 LCAs (Δ 0 heavier vs KBI Biopharma, Inc.); CERT-CLEAN · WAGE-BELOW vs this page's MICRO-BOOK · CERT-SOLID · WAGE-PAR.
JPMorgan Chase& Co. · LARGEST-distance pole
NC pole at 13,804 LCAs stamps MEGA-BOOK · CERT-LOCK, farthest ABS(total_petitions) contrast from KBI Biopharma, Inc.'s MICRO-BOOK.
NC worksite board · MICRO-BOOK
Open the NC state board after the ABS peers. KBI Biopharma, Inc. stamps MICRO-BOOK · CERT-SOLID inside that worksite mix.
LCA process primer · CERT-SOLID
KBI Biopharma, Inc.'s CERT-SOLID stamp sits below CERT-CLEAN. Start with how LCA certification works.
What to do with this profile
Use the DOL LCA record for KBI Biopharma, Inc. to compare filing volume and offered wages, not USCIS outcomes.
- KBI Biopharma, Inc. filed 67 LCAs in the indexed extract (92.5% certified in-file). That volume ranks higher than 97% of employer filers.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in NC rank on LCA filing volume this vintage. NC filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.